Paper Details
- Home
- Paper Details
Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
Author: CaoLihuan, JiangSongmin, LiuZulong, QuShijin, TanChangheng, TangLisha, YangXianmei, YuLong, YuWenbo, ZhuDayuan, ZhuHengrui
Original Abstract of the Article :
BACKGROUND: Multi-drug resistance (MDR) remains a major impediment in cancer therapy. A major goal for scientists is to discover more effective compounds that are able to circumvent MDR and simultaneously have minimal adverse side effects. OBJECTIVE: In the present study, we aim to determine the an...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.2174/1871520617666170803155025
データ提供:米国国立医学図書館(NLM)
Overcoming Multi-Drug Resistance in Cancer: The Role of Pyramidatine
Multi-drug resistance (MDR) is a significant obstacle in cancer treatment, often leading to treatment failure. This study investigates the potential of pyramidatine, a naturally occurring compound, in overcoming MDR in cancer cells. The researchers examined the effects of pyramidatine on vincristine-resistant human oral cancer cells (KB/VCR) and adriamycin-resistant human breast adenocarcinoma cells (MCF-7/ADR), evaluating its ability to enhance the effectiveness of chemotherapeutic agents.Pyramidatine Shows Promise as an MDR Reversal Agent
The study found that pyramidatine significantly enhanced the cytotoxicity of vincristine towards KB/VCR cells. It also demonstrated that pyramidatine could inhibit the function and expression of P-glycoprotein (P-gp), a protein that pumps chemotherapeutic drugs out of cancer cells, thus contributing to MDR. These findings suggest that pyramidatine holds promise as a potential MDR reversal agent.Fighting Cancer Resistance: A New Weapon in the Arsenal
This research provides a valuable contribution to the ongoing efforts to overcome MDR in cancer treatment. The findings suggest that pyramidatine could be a valuable tool in enhancing the effectiveness of chemotherapy drugs. Think of it like this: a camel traversing a desert might need to use a special tool to navigate a steep incline. Similarly, researchers are looking for tools to help them overcome the challenges of MDR in cancer therapy.Dr. Camel's Conclusion
This study is a testament to the importance of ongoing research to find innovative solutions to overcome MDR in cancer. The promising results with pyramidatine offer hope for a more effective approach to treating drug-resistant cancers. The ongoing search for solutions to conquer MDR is a journey that requires perseverance, just like a camel navigating a vast and challenging desert.Date :
- Date Completed 2019-07-29
- Date Revised 2019-09-11
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.